ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Glenmark Pharmaceuticals Europe R&D Limited

Glenmark Pharmaceuticals Europe R&D Limited is a dissolved company incorporated on 7 November 2007 with the registered office located in Harrow, Greater London. Glenmark Pharmaceuticals Europe R&D Limited was registered 17 years ago.
Status
Dissolved
Dissolved on 4 January 2022 (3 years ago)
Was 14 years old at the time of dissolution
Via voluntary strike-off
Company No
06420547
Private limited company
Age
17 years
Incorporated 7 November 2007
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
Laxmi House 2-B Draycott Avenue
Kenton
Harrow
Middlesex
HA3 0BU
Same address for the past 10 years
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
1
Shareholders
1
Controllers (PSC)
3
Director • None • British • Lives in UK • Born in Jun 1980
Ms Blanche Elizabeth Saldanha
PSC • Indian • Lives in India • Born in Jul 1940
Mrs Cherylann Pinto
PSC • Indian • Lives in India • Born in Jan 1967
Mr Glenn Saldanha
PSC • Indian • Lives in India • Born in Nov 1969
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Glenmark Pharmaceuticals Europe Limited
Oliver Henry Bourne is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2012–2021)
Period Ended
31 Mar 2021
For period 31 Mar31 Mar 2021
Traded for 12 months
Cash in Bank
£976.52K
Decreased by £2.16M (-69%)
Turnover
£1.91M
Decreased by £2.1M (-52%)
Employees
13
Same as previous period
Total Assets
£3.93M
Decreased by £156.05K (-4%)
Total Liabilities
-£447.06K
Decreased by £273.39K (-38%)
Net Assets
£3.48M
Increased by £117.34K (+3%)
Debt Ratio (%)
11%
Decreased by 6.26% (-35%)
Latest Activity
Voluntarily Dissolution
3 Years Ago on 4 Jan 2022
Small Accounts Submitted
3 Years Ago on 21 Dec 2021
Voluntary Gazette Notice
3 Years Ago on 19 Oct 2021
Application To Strike Off
3 Years Ago on 8 Oct 2021
Achin Gupta Resigned
4 Years Ago on 20 Aug 2021
Confirmation Submitted
4 Years Ago on 12 Mar 2021
Small Accounts Submitted
4 Years Ago on 16 Dec 2020
Mr Glenn Saldanha (PSC) Details Changed
5 Years Ago on 21 May 2020
Confirmation Submitted
5 Years Ago on 20 Feb 2020
Small Accounts Submitted
5 Years Ago on 19 Sep 2019
Get Credit Report
Discover Glenmark Pharmaceuticals Europe R&D Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 4 Jan 2022
Accounts for a small company made up to 31 March 2021
Submitted on 21 Dec 2021
First Gazette notice for voluntary strike-off
Submitted on 19 Oct 2021
Application to strike the company off the register
Submitted on 8 Oct 2021
Termination of appointment of Achin Gupta as a director on 20 August 2021
Submitted on 25 Aug 2021
Resolutions
Submitted on 22 Apr 2021
Solvency Statement dated 12/04/21
Submitted on 22 Apr 2021
Statement of capital on 22 April 2021
Submitted on 22 Apr 2021
Statement by Directors
Submitted on 22 Apr 2021
Confirmation statement made on 31 January 2021 with no updates
Submitted on 12 Mar 2021
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year